ARTMS™ Products Inc. is a leader in the development of novel technologies and products which enable the production of the world’s most-used diagnostic imaging isotope, technetium‐99m (Tc‐99m), using local, hospital-based medical cyclotrons. ARTMS holds the exclusive global commercialization rights to award-winning and proprietary Canadian inventions which address these challenges and which offer the prospect of revolutionizing the nuclear medicine industry. 

ARTMS™ Products Inc. hardware, such as this target capsule, will enable direct technetium-99m production on a hospital-based cyclotron.

ARTMS™ Products Inc. hardware, such as this target capsule, will enable direct technetium-99m production on a hospital-based cyclotron.

Contact us: info@artmsproductsinc.com